Please login to the form below

Not currently logged in
Email:
Password:

NanoValent promotes Mark Lewis to COO

He will also continue to manage the group’s business operations

NanoValent Mark LewisUK and US-based NanoValent Pharmaceuticals has promoted Mark Lewis to chief operating officer.

Lewis brings over 30 years of international commercial and operations expertise - gained primarily in the area of oncology - to the role, and first joined the early-stage oncology group in 2015.

He has worked at a number of pharmaceutical firms including Amersham International (now GE), Chiron (now Novartis) and Farmitalia (now Pfizer).

In addition to his pharmaceutical experience, Lewis also spent 10 years as a management consultant, working at Hill & Knowlton and Quintiles.

Most recently, Lewis served as managing director for Europe at SuperGen (now Otsuka Pharmaceutical) between 2006 and 2010, and was senior vice president of Ascalon Inc from 2010 until 2012.

8th August 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics